Global Meperidine (Demerol) Market, by Dosage Form (Tablets, Injection, and Syrup), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 2,089.1 Mn in 2020 and is expected to increase to US$ 2,784.3 Mn by 2027, witnessing a CAGR of 4.2% during the forecast period (2020-2027) as highlighted in a new report published by Coherent Market Insights.

Manufacturers are engaged in developing new meperidine (Demerol) products for pain management, which has led to an increase in product launches and approvals. This is expected to boost the global meperidine (Demerol) market growth. For instance, in 2015, Epic Pharma, launched generic meperidine in the U.S. for the relief of moderate to severe pain in 50-mg and 100-mg dosage strengths in 100 count bottles. Moreover, manufacturers such as Pfizer, Inc., Hikma Pharmaceuticals, and others also offer branded as well as generic meperidine in the market.

Browse 24 Market Data Tables, and 26 Figures spread through 140 Pages and in-depth TOC on Global Meperidine (Demerol) Market, by Dosage Form (Tablets, Injection, and Syrup), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3816

The rising prevalence of chronic diseases such as cancer and pain associated diseases is expected to result in higher use of potent opioid medications for pain management. Moreover, meperidine is used as a drug for post-operative pain. Meperidine has advantages such as providing very short analgesia which is appropriate for minimally invasive surgeries. Moreover, the growing preference for minimally invasive surgeries is also expected to support growth of the market during the forecast period. For instance, according a study published in January 2020 in Jama Network (The Journal of the American Medical Association), the use of robotic surgeries for all procedures had increased from 1.8% to 15.1% from 2012 to 2018 in the U.S. These factors are expected to support global meperidine (Demerol) market growth during the forecast period.

The increasing number of surgical procedures are expected to drive the global meperidine (Demerol) market growth

Opioids such as meperidine are used as pre-anesthetic medication in the surgical procedure, and are also used as part of anesthesia to prevent pain after surgical procedure. Opioids are also used in surgical treatment related to cancer. They are also used in cardiovascular procedures to obtain the relief from post-surgical treatment pain. The increasing number of surgeries worldwide is expected to support growth of the market during the forecast period. For instance, according to Eurostat, 2019, there were at least 1.4 million caesarean sections performed in the EU in 2017. Moreover, pain management related to cancer disease, back pain, neuropathic pain, migraine, osteoarthritis, and pain which occurs after the surgical procedures also involves use of opioids such as meperidine. The rising prevalence of such diseases is expected to support global meperidine (Demerol) market growth during the forecast period.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/meperidine-market-3816

Key takeaways of the global meperidine (Demerol) market:

The global meperidine (Demerol) market is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027) owing to product approvals and launches as well as increasing prevalence of chronic diseases requiring surgical intervention.

On the basis of dosage form, the injection segment is expected to hold a dominant position in the global meperidine (Demerol) market during the forecast period owing to high use in post-operative pain management and post pregnancy pain management.

Based on distribution channel, the hospital pharmacies segment is expected to witness significant growth due to increasing use of meperidine in post-operative pain management as it would be sold through hospital pharmacies.

Some of the major players involved in the global meperidine (Demerol) market are Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., and Vintage Pharmaceuticals, Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3816

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737